Global Cell Line Development for Biologics Market Growth (Status and Outlook) 2023-2029
The report requires updating with new data and is sent in 48 hours after order is placed.
The global Cell Line Development for Biologics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cell Line Development for Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cell Line Development for Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cell Line Development for Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cell Line Development for Biologics players cover Lonza, Corning, Sartorius, Thermo Fisher Scientific, Selexis, Beckman Coulter (Danaher ), CYTENA, Molecular Devices and Samsung Biologics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Cell line development is a critical step in the production of biologics. Biologics are complex molecules that are produced by living cells, such as proteins, antibodies, and vaccines. To produce biologics in large quantities, scientists need to develop cell lines that can produce these molecules consistently and at high levels.
LPI (LP Information)' newest research report, the “Cell Line Development for Biologics Industry Forecast” looks at past sales and reviews total world Cell Line Development for Biologics sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell Line Development for Biologics sales for 2023 through 2029. With Cell Line Development for Biologics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Line Development for Biologics industry.
This Insight Report provides a comprehensive analysis of the global Cell Line Development for Biologics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell Line Development for Biologics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Line Development for Biologics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Line Development for Biologics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Line Development for Biologics.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Line Development for Biologics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
The global Cell Line Development for Biologics market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.
United States market for Cell Line Development for Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
China market for Cell Line Development for Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Europe market for Cell Line Development for Biologics is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.
Global key Cell Line Development for Biologics players cover Lonza, Corning, Sartorius, Thermo Fisher Scientific, Selexis, Beckman Coulter (Danaher ), CYTENA, Molecular Devices and Samsung Biologics, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.
Cell line development is a critical step in the production of biologics. Biologics are complex molecules that are produced by living cells, such as proteins, antibodies, and vaccines. To produce biologics in large quantities, scientists need to develop cell lines that can produce these molecules consistently and at high levels.
LPI (LP Information)' newest research report, the “Cell Line Development for Biologics Industry Forecast” looks at past sales and reviews total world Cell Line Development for Biologics sales in 2022, providing a comprehensive analysis by region and market sector of projected Cell Line Development for Biologics sales for 2023 through 2029. With Cell Line Development for Biologics sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Cell Line Development for Biologics industry.
This Insight Report provides a comprehensive analysis of the global Cell Line Development for Biologics landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Cell Line Development for Biologics portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Cell Line Development for Biologics market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Cell Line Development for Biologics and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Cell Line Development for Biologics.
This report presents a comprehensive overview, market shares, and growth opportunities of Cell Line Development for Biologics market by product type, application, key players and key regions and countries.
Market Segmentation:
Segmentation by type
- CHO Cell Lines
- HEK293 Cell Lines
- Insect Cell Lines
- Monoclonal Antibodies
- Recombinant Proteins
- Vaccines
- Americas
- United States
- Canada
- Mexico
- Brazil
- APAC
- China
- Japan
- Korea
- Southeast Asia
- India
- Australia
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Middle East & Africa
- Egypt
- South Africa
- Israel
- Turkey
- GCC Countries
- Lonza
- Corning
- Sartorius
- Thermo Fisher Scientific
- Selexis
- Beckman Coulter (Danaher )
- CYTENA
- Molecular Devices
- Samsung Biologics
- Hera BioLabs
- GTP Bioways
- Abzena
- FyoniBio
- Catalent
- WuXi Biologics
1 SCOPE OF THE REPORT
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell Line Development for Biologics Market Size 2018-2029
2.1.2 Cell Line Development for Biologics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cell Line Development for Biologics Segment by Type
2.2.1 CHO Cell Lines
2.2.2 HEK293 Cell Lines
2.2.3 Insect Cell Lines
2.3 Cell Line Development for Biologics Market Size by Type
2.3.1 Cell Line Development for Biologics Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Cell Line Development for Biologics Market Size Market Share by Type (2018-2023)
2.4 Cell Line Development for Biologics Segment by Application
2.4.1 Monoclonal Antibodies
2.4.2 Recombinant Proteins
2.4.3 Vaccines
2.5 Cell Line Development for Biologics Market Size by Application
2.5.1 Cell Line Development for Biologics Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Cell Line Development for Biologics Market Size Market Share by Application (2018-2023)
3 CELL LINE DEVELOPMENT FOR BIOLOGICS MARKET SIZE BY PLAYER
3.1 Cell Line Development for Biologics Market Size Market Share by Players
3.1.1 Global Cell Line Development for Biologics Revenue by Players (2018-2023)
3.1.2 Global Cell Line Development for Biologics Revenue Market Share by Players (2018-2023)
3.2 Global Cell Line Development for Biologics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL LINE DEVELOPMENT FOR BIOLOGICS BY REGIONS
4.1 Cell Line Development for Biologics Market Size by Regions (2018-2023)
4.2 Americas Cell Line Development for Biologics Market Size Growth (2018-2023)
4.3 APAC Cell Line Development for Biologics Market Size Growth (2018-2023)
4.4 Europe Cell Line Development for Biologics Market Size Growth (2018-2023)
4.5 Middle East & Africa Cell Line Development for Biologics Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Cell Line Development for Biologics Market Size by Country (2018-2023)
5.2 Americas Cell Line Development for Biologics Market Size by Type (2018-2023)
5.3 Americas Cell Line Development for Biologics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell Line Development for Biologics Market Size by Region (2018-2023)
6.2 APAC Cell Line Development for Biologics Market Size by Type (2018-2023)
6.3 APAC Cell Line Development for Biologics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell Line Development for Biologics by Country (2018-2023)
7.2 Europe Cell Line Development for Biologics Market Size by Type (2018-2023)
7.3 Europe Cell Line Development for Biologics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell Line Development for Biologics by Region (2018-2023)
8.2 Middle East & Africa Cell Line Development for Biologics Market Size by Type (2018-2023)
8.3 Middle East & Africa Cell Line Development for Biologics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL LINE DEVELOPMENT FOR BIOLOGICS MARKET FORECAST
10.1 Global Cell Line Development for Biologics Forecast by Regions (2024-2029)
10.1.1 Global Cell Line Development for Biologics Forecast by Regions (2024-2029)
10.1.2 Americas Cell Line Development for Biologics Forecast
10.1.3 APAC Cell Line Development for Biologics Forecast
10.1.4 Europe Cell Line Development for Biologics Forecast
10.1.5 Middle East & Africa Cell Line Development for Biologics Forecast
10.2 Americas Cell Line Development for Biologics Forecast by Country (2024-2029)
10.2.1 United States Cell Line Development for Biologics Market Forecast
10.2.2 Canada Cell Line Development for Biologics Market Forecast
10.2.3 Mexico Cell Line Development for Biologics Market Forecast
10.2.4 Brazil Cell Line Development for Biologics Market Forecast
10.3 APAC Cell Line Development for Biologics Forecast by Region (2024-2029)
10.3.1 China Cell Line Development for Biologics Market Forecast
10.3.2 Japan Cell Line Development for Biologics Market Forecast
10.3.3 Korea Cell Line Development for Biologics Market Forecast
10.3.4 Southeast Asia Cell Line Development for Biologics Market Forecast
10.3.5 India Cell Line Development for Biologics Market Forecast
10.3.6 Australia Cell Line Development for Biologics Market Forecast
10.4 Europe Cell Line Development for Biologics Forecast by Country (2024-2029)
10.4.1 Germany Cell Line Development for Biologics Market Forecast
10.4.2 France Cell Line Development for Biologics Market Forecast
10.4.3 UK Cell Line Development for Biologics Market Forecast
10.4.4 Italy Cell Line Development for Biologics Market Forecast
10.4.5 Russia Cell Line Development for Biologics Market Forecast
10.5 Middle East & Africa Cell Line Development for Biologics Forecast by Region (2024-2029)
10.5.1 Egypt Cell Line Development for Biologics Market Forecast
10.5.2 South Africa Cell Line Development for Biologics Market Forecast
10.5.3 Israel Cell Line Development for Biologics Market Forecast
10.5.4 Turkey Cell Line Development for Biologics Market Forecast
10.5.5 GCC Countries Cell Line Development for Biologics Market Forecast
10.6 Global Cell Line Development for Biologics Forecast by Type (2024-2029)
10.7 Global Cell Line Development for Biologics Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Cell Line Development for Biologics Product Offered
11.1.3 Lonza Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Corning
11.2.1 Corning Company Information
11.2.2 Corning Cell Line Development for Biologics Product Offered
11.2.3 Corning Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Corning Main Business Overview
11.2.5 Corning Latest Developments
11.3 Sartorius
11.3.1 Sartorius Company Information
11.3.2 Sartorius Cell Line Development for Biologics Product Offered
11.3.3 Sartorius Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Sartorius Main Business Overview
11.3.5 Sartorius Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Cell Line Development for Biologics Product Offered
11.4.3 Thermo Fisher Scientific Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Selexis
11.5.1 Selexis Company Information
11.5.2 Selexis Cell Line Development for Biologics Product Offered
11.5.3 Selexis Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Selexis Main Business Overview
11.5.5 Selexis Latest Developments
11.6 Beckman Coulter (Danaher )
11.6.1 Beckman Coulter (Danaher ) Company Information
11.6.2 Beckman Coulter (Danaher ) Cell Line Development for Biologics Product Offered
11.6.3 Beckman Coulter (Danaher ) Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Beckman Coulter (Danaher ) Main Business Overview
11.6.5 Beckman Coulter (Danaher ) Latest Developments
11.7 CYTENA
11.7.1 CYTENA Company Information
11.7.2 CYTENA Cell Line Development for Biologics Product Offered
11.7.3 CYTENA Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 CYTENA Main Business Overview
11.7.5 CYTENA Latest Developments
11.8 Molecular Devices
11.8.1 Molecular Devices Company Information
11.8.2 Molecular Devices Cell Line Development for Biologics Product Offered
11.8.3 Molecular Devices Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Molecular Devices Main Business Overview
11.8.5 Molecular Devices Latest Developments
11.9 Samsung Biologics
11.9.1 Samsung Biologics Company Information
11.9.2 Samsung Biologics Cell Line Development for Biologics Product Offered
11.9.3 Samsung Biologics Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Samsung Biologics Main Business Overview
11.9.5 Samsung Biologics Latest Developments
11.10 Hera BioLabs
11.10.1 Hera BioLabs Company Information
11.10.2 Hera BioLabs Cell Line Development for Biologics Product Offered
11.10.3 Hera BioLabs Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Hera BioLabs Main Business Overview
11.10.5 Hera BioLabs Latest Developments
11.11 GTP Bioways
11.11.1 GTP Bioways Company Information
11.11.2 GTP Bioways Cell Line Development for Biologics Product Offered
11.11.3 GTP Bioways Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 GTP Bioways Main Business Overview
11.11.5 GTP Bioways Latest Developments
11.12 Abzena
11.12.1 Abzena Company Information
11.12.2 Abzena Cell Line Development for Biologics Product Offered
11.12.3 Abzena Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Abzena Main Business Overview
11.12.5 Abzena Latest Developments
11.13 FyoniBio
11.13.1 FyoniBio Company Information
11.13.2 FyoniBio Cell Line Development for Biologics Product Offered
11.13.3 FyoniBio Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 FyoniBio Main Business Overview
11.13.5 FyoniBio Latest Developments
11.14 Catalent
11.14.1 Catalent Company Information
11.14.2 Catalent Cell Line Development for Biologics Product Offered
11.14.3 Catalent Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Catalent Main Business Overview
11.14.5 Catalent Latest Developments
11.15 WuXi Biologics
11.15.1 WuXi Biologics Company Information
11.15.2 WuXi Biologics Cell Line Development for Biologics Product Offered
11.15.3 WuXi Biologics Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 WuXi Biologics Main Business Overview
11.15.5 WuXi Biologics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats
2 EXECUTIVE SUMMARY
2.1 World Market Overview
2.1.1 Global Cell Line Development for Biologics Market Size 2018-2029
2.1.2 Cell Line Development for Biologics Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Cell Line Development for Biologics Segment by Type
2.2.1 CHO Cell Lines
2.2.2 HEK293 Cell Lines
2.2.3 Insect Cell Lines
2.3 Cell Line Development for Biologics Market Size by Type
2.3.1 Cell Line Development for Biologics Market Size CAGR by Type (2018 VS 2022 VS 2029)
2.3.2 Global Cell Line Development for Biologics Market Size Market Share by Type (2018-2023)
2.4 Cell Line Development for Biologics Segment by Application
2.4.1 Monoclonal Antibodies
2.4.2 Recombinant Proteins
2.4.3 Vaccines
2.5 Cell Line Development for Biologics Market Size by Application
2.5.1 Cell Line Development for Biologics Market Size CAGR by Application (2018 VS 2022 VS 2029)
2.5.2 Global Cell Line Development for Biologics Market Size Market Share by Application (2018-2023)
3 CELL LINE DEVELOPMENT FOR BIOLOGICS MARKET SIZE BY PLAYER
3.1 Cell Line Development for Biologics Market Size Market Share by Players
3.1.1 Global Cell Line Development for Biologics Revenue by Players (2018-2023)
3.1.2 Global Cell Line Development for Biologics Revenue Market Share by Players (2018-2023)
3.2 Global Cell Line Development for Biologics Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
3.3.1 Competition Landscape Analysis
3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion
4 CELL LINE DEVELOPMENT FOR BIOLOGICS BY REGIONS
4.1 Cell Line Development for Biologics Market Size by Regions (2018-2023)
4.2 Americas Cell Line Development for Biologics Market Size Growth (2018-2023)
4.3 APAC Cell Line Development for Biologics Market Size Growth (2018-2023)
4.4 Europe Cell Line Development for Biologics Market Size Growth (2018-2023)
4.5 Middle East & Africa Cell Line Development for Biologics Market Size Growth (2018-2023)
5 AMERICAS
5.1 Americas Cell Line Development for Biologics Market Size by Country (2018-2023)
5.2 Americas Cell Line Development for Biologics Market Size by Type (2018-2023)
5.3 Americas Cell Line Development for Biologics Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Cell Line Development for Biologics Market Size by Region (2018-2023)
6.2 APAC Cell Line Development for Biologics Market Size by Type (2018-2023)
6.3 APAC Cell Line Development for Biologics Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
7 EUROPE
7.1 Europe Cell Line Development for Biologics by Country (2018-2023)
7.2 Europe Cell Line Development for Biologics Market Size by Type (2018-2023)
7.3 Europe Cell Line Development for Biologics Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 MIDDLE EAST & AFRICA
8.1 Middle East & Africa Cell Line Development for Biologics by Region (2018-2023)
8.2 Middle East & Africa Cell Line Development for Biologics Market Size by Type (2018-2023)
8.3 Middle East & Africa Cell Line Development for Biologics Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 MARKET DRIVERS, CHALLENGES AND TRENDS
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 GLOBAL CELL LINE DEVELOPMENT FOR BIOLOGICS MARKET FORECAST
10.1 Global Cell Line Development for Biologics Forecast by Regions (2024-2029)
10.1.1 Global Cell Line Development for Biologics Forecast by Regions (2024-2029)
10.1.2 Americas Cell Line Development for Biologics Forecast
10.1.3 APAC Cell Line Development for Biologics Forecast
10.1.4 Europe Cell Line Development for Biologics Forecast
10.1.5 Middle East & Africa Cell Line Development for Biologics Forecast
10.2 Americas Cell Line Development for Biologics Forecast by Country (2024-2029)
10.2.1 United States Cell Line Development for Biologics Market Forecast
10.2.2 Canada Cell Line Development for Biologics Market Forecast
10.2.3 Mexico Cell Line Development for Biologics Market Forecast
10.2.4 Brazil Cell Line Development for Biologics Market Forecast
10.3 APAC Cell Line Development for Biologics Forecast by Region (2024-2029)
10.3.1 China Cell Line Development for Biologics Market Forecast
10.3.2 Japan Cell Line Development for Biologics Market Forecast
10.3.3 Korea Cell Line Development for Biologics Market Forecast
10.3.4 Southeast Asia Cell Line Development for Biologics Market Forecast
10.3.5 India Cell Line Development for Biologics Market Forecast
10.3.6 Australia Cell Line Development for Biologics Market Forecast
10.4 Europe Cell Line Development for Biologics Forecast by Country (2024-2029)
10.4.1 Germany Cell Line Development for Biologics Market Forecast
10.4.2 France Cell Line Development for Biologics Market Forecast
10.4.3 UK Cell Line Development for Biologics Market Forecast
10.4.4 Italy Cell Line Development for Biologics Market Forecast
10.4.5 Russia Cell Line Development for Biologics Market Forecast
10.5 Middle East & Africa Cell Line Development for Biologics Forecast by Region (2024-2029)
10.5.1 Egypt Cell Line Development for Biologics Market Forecast
10.5.2 South Africa Cell Line Development for Biologics Market Forecast
10.5.3 Israel Cell Line Development for Biologics Market Forecast
10.5.4 Turkey Cell Line Development for Biologics Market Forecast
10.5.5 GCC Countries Cell Line Development for Biologics Market Forecast
10.6 Global Cell Line Development for Biologics Forecast by Type (2024-2029)
10.7 Global Cell Line Development for Biologics Forecast by Application (2024-2029)
11 KEY PLAYERS ANALYSIS
11.1 Lonza
11.1.1 Lonza Company Information
11.1.2 Lonza Cell Line Development for Biologics Product Offered
11.1.3 Lonza Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.1.4 Lonza Main Business Overview
11.1.5 Lonza Latest Developments
11.2 Corning
11.2.1 Corning Company Information
11.2.2 Corning Cell Line Development for Biologics Product Offered
11.2.3 Corning Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.2.4 Corning Main Business Overview
11.2.5 Corning Latest Developments
11.3 Sartorius
11.3.1 Sartorius Company Information
11.3.2 Sartorius Cell Line Development for Biologics Product Offered
11.3.3 Sartorius Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.3.4 Sartorius Main Business Overview
11.3.5 Sartorius Latest Developments
11.4 Thermo Fisher Scientific
11.4.1 Thermo Fisher Scientific Company Information
11.4.2 Thermo Fisher Scientific Cell Line Development for Biologics Product Offered
11.4.3 Thermo Fisher Scientific Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.4.4 Thermo Fisher Scientific Main Business Overview
11.4.5 Thermo Fisher Scientific Latest Developments
11.5 Selexis
11.5.1 Selexis Company Information
11.5.2 Selexis Cell Line Development for Biologics Product Offered
11.5.3 Selexis Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.5.4 Selexis Main Business Overview
11.5.5 Selexis Latest Developments
11.6 Beckman Coulter (Danaher )
11.6.1 Beckman Coulter (Danaher ) Company Information
11.6.2 Beckman Coulter (Danaher ) Cell Line Development for Biologics Product Offered
11.6.3 Beckman Coulter (Danaher ) Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.6.4 Beckman Coulter (Danaher ) Main Business Overview
11.6.5 Beckman Coulter (Danaher ) Latest Developments
11.7 CYTENA
11.7.1 CYTENA Company Information
11.7.2 CYTENA Cell Line Development for Biologics Product Offered
11.7.3 CYTENA Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.7.4 CYTENA Main Business Overview
11.7.5 CYTENA Latest Developments
11.8 Molecular Devices
11.8.1 Molecular Devices Company Information
11.8.2 Molecular Devices Cell Line Development for Biologics Product Offered
11.8.3 Molecular Devices Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.8.4 Molecular Devices Main Business Overview
11.8.5 Molecular Devices Latest Developments
11.9 Samsung Biologics
11.9.1 Samsung Biologics Company Information
11.9.2 Samsung Biologics Cell Line Development for Biologics Product Offered
11.9.3 Samsung Biologics Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.9.4 Samsung Biologics Main Business Overview
11.9.5 Samsung Biologics Latest Developments
11.10 Hera BioLabs
11.10.1 Hera BioLabs Company Information
11.10.2 Hera BioLabs Cell Line Development for Biologics Product Offered
11.10.3 Hera BioLabs Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.10.4 Hera BioLabs Main Business Overview
11.10.5 Hera BioLabs Latest Developments
11.11 GTP Bioways
11.11.1 GTP Bioways Company Information
11.11.2 GTP Bioways Cell Line Development for Biologics Product Offered
11.11.3 GTP Bioways Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.11.4 GTP Bioways Main Business Overview
11.11.5 GTP Bioways Latest Developments
11.12 Abzena
11.12.1 Abzena Company Information
11.12.2 Abzena Cell Line Development for Biologics Product Offered
11.12.3 Abzena Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.12.4 Abzena Main Business Overview
11.12.5 Abzena Latest Developments
11.13 FyoniBio
11.13.1 FyoniBio Company Information
11.13.2 FyoniBio Cell Line Development for Biologics Product Offered
11.13.3 FyoniBio Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.13.4 FyoniBio Main Business Overview
11.13.5 FyoniBio Latest Developments
11.14 Catalent
11.14.1 Catalent Company Information
11.14.2 Catalent Cell Line Development for Biologics Product Offered
11.14.3 Catalent Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.14.4 Catalent Main Business Overview
11.14.5 Catalent Latest Developments
11.15 WuXi Biologics
11.15.1 WuXi Biologics Company Information
11.15.2 WuXi Biologics Cell Line Development for Biologics Product Offered
11.15.3 WuXi Biologics Cell Line Development for Biologics Revenue, Gross Margin and Market Share (2018-2023)
11.15.4 WuXi Biologics Main Business Overview
11.15.5 WuXi Biologics Latest Developments
12 RESEARCH FINDINGS AND CONCLUSION
LIST OF TABLES
Table 1. Cell Line Development for Biologics Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of CHO Cell Lines
Table 3. Major Players of HEK293 Cell Lines
Table 4. Major Players of Insect Cell Lines
Table 5. Cell Line Development for Biologics Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Cell Line Development for Biologics Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Cell Line Development for Biologics Market Size Market Share by Type (2018-2023)
Table 8. Cell Line Development for Biologics Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Cell Line Development for Biologics Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Cell Line Development for Biologics Market Size Market Share by Application (2018-2023)
Table 11. Global Cell Line Development for Biologics Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Cell Line Development for Biologics Revenue Market Share by Player (2018-2023)
Table 13. Cell Line Development for Biologics Key Players Head office and Products Offered
Table 14. Cell Line Development for Biologics Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cell Line Development for Biologics Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Cell Line Development for Biologics Market Size Market Share by Regions (2018-2023)
Table 19. Global Cell Line Development for Biologics Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Cell Line Development for Biologics Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Cell Line Development for Biologics Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Cell Line Development for Biologics Market Size Market Share by Country (2018-2023)
Table 23. Americas Cell Line Development for Biologics Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Cell Line Development for Biologics Market Size Market Share by Type (2018-2023)
Table 25. Americas Cell Line Development for Biologics Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Cell Line Development for Biologics Market Size Market Share by Application (2018-2023)
Table 27. APAC Cell Line Development for Biologics Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Cell Line Development for Biologics Market Size Market Share by Region (2018-2023)
Table 29. APAC Cell Line Development for Biologics Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Cell Line Development for Biologics Market Size Market Share by Type (2018-2023)
Table 31. APAC Cell Line Development for Biologics Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Cell Line Development for Biologics Market Size Market Share by Application (2018-2023)
Table 33. Europe Cell Line Development for Biologics Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Cell Line Development for Biologics Market Size Market Share by Country (2018-2023)
Table 35. Europe Cell Line Development for Biologics Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Cell Line Development for Biologics Market Size Market Share by Type (2018-2023)
Table 37. Europe Cell Line Development for Biologics Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Cell Line Development for Biologics Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Cell Line Development for Biologics Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Cell Line Development for Biologics Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Cell Line Development for Biologics Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Cell Line Development for Biologics Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Cell Line Development for Biologics Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Cell Line Development for Biologics Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Cell Line Development for Biologics
Table 46. Key Market Challenges & Risks of Cell Line Development for Biologics
Table 47. Key Industry Trends of Cell Line Development for Biologics
Table 48. Global Cell Line Development for Biologics Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Cell Line Development for Biologics Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Cell Line Development for Biologics Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Cell Line Development for Biologics Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Lonza Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 53. Lonza Cell Line Development for Biologics Product Offered
Table 54. Lonza Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Lonza Main Business
Table 56. Lonza Latest Developments
Table 57. Corning Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 58. Corning Cell Line Development for Biologics Product Offered
Table 59. Corning Main Business
Table 60. Corning Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Corning Latest Developments
Table 62. Sartorius Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 63. Sartorius Cell Line Development for Biologics Product Offered
Table 64. Sartorius Main Business
Table 65. Sartorius Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Sartorius Latest Developments
Table 67. Thermo Fisher Scientific Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 68. Thermo Fisher Scientific Cell Line Development for Biologics Product Offered
Table 69. Thermo Fisher Scientific Main Business
Table 70. Thermo Fisher Scientific Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Thermo Fisher Scientific Latest Developments
Table 72. Selexis Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 73. Selexis Cell Line Development for Biologics Product Offered
Table 74. Selexis Main Business
Table 75. Selexis Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Selexis Latest Developments
Table 77. Beckman Coulter (Danaher ) Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 78. Beckman Coulter (Danaher ) Cell Line Development for Biologics Product Offered
Table 79. Beckman Coulter (Danaher ) Main Business
Table 80. Beckman Coulter (Danaher ) Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Beckman Coulter (Danaher ) Latest Developments
Table 82. CYTENA Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 83. CYTENA Cell Line Development for Biologics Product Offered
Table 84. CYTENA Main Business
Table 85. CYTENA Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. CYTENA Latest Developments
Table 87. Molecular Devices Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 88. Molecular Devices Cell Line Development for Biologics Product Offered
Table 89. Molecular Devices Main Business
Table 90. Molecular Devices Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Molecular Devices Latest Developments
Table 92. Samsung Biologics Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 93. Samsung Biologics Cell Line Development for Biologics Product Offered
Table 94. Samsung Biologics Main Business
Table 95. Samsung Biologics Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Samsung Biologics Latest Developments
Table 97. Hera BioLabs Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 98. Hera BioLabs Cell Line Development for Biologics Product Offered
Table 99. Hera BioLabs Main Business
Table 100. Hera BioLabs Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Hera BioLabs Latest Developments
Table 102. GTP Bioways Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 103. GTP Bioways Cell Line Development for Biologics Product Offered
Table 104. GTP Bioways Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. GTP Bioways Main Business
Table 106. GTP Bioways Latest Developments
Table 107. Abzena Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 108. Abzena Cell Line Development for Biologics Product Offered
Table 109. Abzena Main Business
Table 110. Abzena Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Abzena Latest Developments
Table 112. FyoniBio Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 113. FyoniBio Cell Line Development for Biologics Product Offered
Table 114. FyoniBio Main Business
Table 115. FyoniBio Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. FyoniBio Latest Developments
Table 117. Catalent Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 118. Catalent Cell Line Development for Biologics Product Offered
Table 119. Catalent Main Business
Table 120. Catalent Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Catalent Latest Developments
Table 122. WuXi Biologics Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 123. WuXi Biologics Cell Line Development for Biologics Product Offered
Table 124. WuXi Biologics Main Business
Table 125. WuXi Biologics Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. WuXi Biologics Latest Developments
Table 1. Cell Line Development for Biologics Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of CHO Cell Lines
Table 3. Major Players of HEK293 Cell Lines
Table 4. Major Players of Insect Cell Lines
Table 5. Cell Line Development for Biologics Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 6. Global Cell Line Development for Biologics Market Size by Type (2018-2023) & ($ Millions)
Table 7. Global Cell Line Development for Biologics Market Size Market Share by Type (2018-2023)
Table 8. Cell Line Development for Biologics Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 9. Global Cell Line Development for Biologics Market Size by Application (2018-2023) & ($ Millions)
Table 10. Global Cell Line Development for Biologics Market Size Market Share by Application (2018-2023)
Table 11. Global Cell Line Development for Biologics Revenue by Players (2018-2023) & ($ Millions)
Table 12. Global Cell Line Development for Biologics Revenue Market Share by Player (2018-2023)
Table 13. Cell Line Development for Biologics Key Players Head office and Products Offered
Table 14. Cell Line Development for Biologics Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Cell Line Development for Biologics Market Size by Regions 2018-2023 & ($ Millions)
Table 18. Global Cell Line Development for Biologics Market Size Market Share by Regions (2018-2023)
Table 19. Global Cell Line Development for Biologics Revenue by Country/Region (2018-2023) & ($ millions)
Table 20. Global Cell Line Development for Biologics Revenue Market Share by Country/Region (2018-2023)
Table 21. Americas Cell Line Development for Biologics Market Size by Country (2018-2023) & ($ Millions)
Table 22. Americas Cell Line Development for Biologics Market Size Market Share by Country (2018-2023)
Table 23. Americas Cell Line Development for Biologics Market Size by Type (2018-2023) & ($ Millions)
Table 24. Americas Cell Line Development for Biologics Market Size Market Share by Type (2018-2023)
Table 25. Americas Cell Line Development for Biologics Market Size by Application (2018-2023) & ($ Millions)
Table 26. Americas Cell Line Development for Biologics Market Size Market Share by Application (2018-2023)
Table 27. APAC Cell Line Development for Biologics Market Size by Region (2018-2023) & ($ Millions)
Table 28. APAC Cell Line Development for Biologics Market Size Market Share by Region (2018-2023)
Table 29. APAC Cell Line Development for Biologics Market Size by Type (2018-2023) & ($ Millions)
Table 30. APAC Cell Line Development for Biologics Market Size Market Share by Type (2018-2023)
Table 31. APAC Cell Line Development for Biologics Market Size by Application (2018-2023) & ($ Millions)
Table 32. APAC Cell Line Development for Biologics Market Size Market Share by Application (2018-2023)
Table 33. Europe Cell Line Development for Biologics Market Size by Country (2018-2023) & ($ Millions)
Table 34. Europe Cell Line Development for Biologics Market Size Market Share by Country (2018-2023)
Table 35. Europe Cell Line Development for Biologics Market Size by Type (2018-2023) & ($ Millions)
Table 36. Europe Cell Line Development for Biologics Market Size Market Share by Type (2018-2023)
Table 37. Europe Cell Line Development for Biologics Market Size by Application (2018-2023) & ($ Millions)
Table 38. Europe Cell Line Development for Biologics Market Size Market Share by Application (2018-2023)
Table 39. Middle East & Africa Cell Line Development for Biologics Market Size by Region (2018-2023) & ($ Millions)
Table 40. Middle East & Africa Cell Line Development for Biologics Market Size Market Share by Region (2018-2023)
Table 41. Middle East & Africa Cell Line Development for Biologics Market Size by Type (2018-2023) & ($ Millions)
Table 42. Middle East & Africa Cell Line Development for Biologics Market Size Market Share by Type (2018-2023)
Table 43. Middle East & Africa Cell Line Development for Biologics Market Size by Application (2018-2023) & ($ Millions)
Table 44. Middle East & Africa Cell Line Development for Biologics Market Size Market Share by Application (2018-2023)
Table 45. Key Market Drivers & Growth Opportunities of Cell Line Development for Biologics
Table 46. Key Market Challenges & Risks of Cell Line Development for Biologics
Table 47. Key Industry Trends of Cell Line Development for Biologics
Table 48. Global Cell Line Development for Biologics Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 49. Global Cell Line Development for Biologics Market Size Market Share Forecast by Regions (2024-2029)
Table 50. Global Cell Line Development for Biologics Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 51. Global Cell Line Development for Biologics Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 52. Lonza Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 53. Lonza Cell Line Development for Biologics Product Offered
Table 54. Lonza Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 55. Lonza Main Business
Table 56. Lonza Latest Developments
Table 57. Corning Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 58. Corning Cell Line Development for Biologics Product Offered
Table 59. Corning Main Business
Table 60. Corning Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 61. Corning Latest Developments
Table 62. Sartorius Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 63. Sartorius Cell Line Development for Biologics Product Offered
Table 64. Sartorius Main Business
Table 65. Sartorius Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 66. Sartorius Latest Developments
Table 67. Thermo Fisher Scientific Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 68. Thermo Fisher Scientific Cell Line Development for Biologics Product Offered
Table 69. Thermo Fisher Scientific Main Business
Table 70. Thermo Fisher Scientific Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 71. Thermo Fisher Scientific Latest Developments
Table 72. Selexis Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 73. Selexis Cell Line Development for Biologics Product Offered
Table 74. Selexis Main Business
Table 75. Selexis Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 76. Selexis Latest Developments
Table 77. Beckman Coulter (Danaher ) Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 78. Beckman Coulter (Danaher ) Cell Line Development for Biologics Product Offered
Table 79. Beckman Coulter (Danaher ) Main Business
Table 80. Beckman Coulter (Danaher ) Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 81. Beckman Coulter (Danaher ) Latest Developments
Table 82. CYTENA Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 83. CYTENA Cell Line Development for Biologics Product Offered
Table 84. CYTENA Main Business
Table 85. CYTENA Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 86. CYTENA Latest Developments
Table 87. Molecular Devices Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 88. Molecular Devices Cell Line Development for Biologics Product Offered
Table 89. Molecular Devices Main Business
Table 90. Molecular Devices Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 91. Molecular Devices Latest Developments
Table 92. Samsung Biologics Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 93. Samsung Biologics Cell Line Development for Biologics Product Offered
Table 94. Samsung Biologics Main Business
Table 95. Samsung Biologics Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 96. Samsung Biologics Latest Developments
Table 97. Hera BioLabs Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 98. Hera BioLabs Cell Line Development for Biologics Product Offered
Table 99. Hera BioLabs Main Business
Table 100. Hera BioLabs Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 101. Hera BioLabs Latest Developments
Table 102. GTP Bioways Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 103. GTP Bioways Cell Line Development for Biologics Product Offered
Table 104. GTP Bioways Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 105. GTP Bioways Main Business
Table 106. GTP Bioways Latest Developments
Table 107. Abzena Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 108. Abzena Cell Line Development for Biologics Product Offered
Table 109. Abzena Main Business
Table 110. Abzena Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 111. Abzena Latest Developments
Table 112. FyoniBio Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 113. FyoniBio Cell Line Development for Biologics Product Offered
Table 114. FyoniBio Main Business
Table 115. FyoniBio Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 116. FyoniBio Latest Developments
Table 117. Catalent Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 118. Catalent Cell Line Development for Biologics Product Offered
Table 119. Catalent Main Business
Table 120. Catalent Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 121. Catalent Latest Developments
Table 122. WuXi Biologics Details, Company Type, Cell Line Development for Biologics Area Served and Its Competitors
Table 123. WuXi Biologics Cell Line Development for Biologics Product Offered
Table 124. WuXi Biologics Main Business
Table 125. WuXi Biologics Cell Line Development for Biologics Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 126. WuXi Biologics Latest Developments
LIST OF FIGURES
Figure 1. Cell Line Development for Biologics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell Line Development for Biologics Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Cell Line Development for Biologics Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Cell Line Development for Biologics Sales Market Share by Country/Region (2022)
Figure 8. Cell Line Development for Biologics Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Cell Line Development for Biologics Market Size Market Share by Type in 2022
Figure 10. Cell Line Development for Biologics in Monoclonal Antibodies
Figure 11. Global Cell Line Development for Biologics Market: Monoclonal Antibodies (2018-2023) & ($ Millions)
Figure 12. Cell Line Development for Biologics in Recombinant Proteins
Figure 13. Global Cell Line Development for Biologics Market: Recombinant Proteins (2018-2023) & ($ Millions)
Figure 14. Cell Line Development for Biologics in Vaccines
Figure 15. Global Cell Line Development for Biologics Market: Vaccines (2018-2023) & ($ Millions)
Figure 16. Global Cell Line Development for Biologics Market Size Market Share by Application in 2022
Figure 17. Global Cell Line Development for Biologics Revenue Market Share by Player in 2022
Figure 18. Global Cell Line Development for Biologics Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Cell Line Development for Biologics Market Size 2018-2023 ($ Millions)
Figure 20. APAC Cell Line Development for Biologics Market Size 2018-2023 ($ Millions)
Figure 21. Europe Cell Line Development for Biologics Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Cell Line Development for Biologics Market Size 2018-2023 ($ Millions)
Figure 23. Americas Cell Line Development for Biologics Value Market Share by Country in 2022
Figure 24. United States Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Cell Line Development for Biologics Market Size Market Share by Region in 2022
Figure 29. APAC Cell Line Development for Biologics Market Size Market Share by Type in 2022
Figure 30. APAC Cell Line Development for Biologics Market Size Market Share by Application in 2022
Figure 31. China Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Cell Line Development for Biologics Market Size Market Share by Country in 2022
Figure 38. Europe Cell Line Development for Biologics Market Size Market Share by Type (2018-2023)
Figure 39. Europe Cell Line Development for Biologics Market Size Market Share by Application (2018-2023)
Figure 40. Germany Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Cell Line Development for Biologics Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Cell Line Development for Biologics Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Cell Line Development for Biologics Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 54. APAC Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 55. Europe Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 57. United States Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 58. Canada Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 61. China Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 62. Japan Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 63. Korea Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 65. India Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 66. Australia Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 67. Germany Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 68. France Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 69. UK Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 70. Italy Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 71. Russia Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 72. Spain Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 75. Israel Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 78. Global Cell Line Development for Biologics Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Cell Line Development for Biologics Market Size Market Share Forecast by Application (2024-2029)
Figure 1. Cell Line Development for Biologics Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Cell Line Development for Biologics Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Cell Line Development for Biologics Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Cell Line Development for Biologics Sales Market Share by Country/Region (2022)
Figure 8. Cell Line Development for Biologics Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Cell Line Development for Biologics Market Size Market Share by Type in 2022
Figure 10. Cell Line Development for Biologics in Monoclonal Antibodies
Figure 11. Global Cell Line Development for Biologics Market: Monoclonal Antibodies (2018-2023) & ($ Millions)
Figure 12. Cell Line Development for Biologics in Recombinant Proteins
Figure 13. Global Cell Line Development for Biologics Market: Recombinant Proteins (2018-2023) & ($ Millions)
Figure 14. Cell Line Development for Biologics in Vaccines
Figure 15. Global Cell Line Development for Biologics Market: Vaccines (2018-2023) & ($ Millions)
Figure 16. Global Cell Line Development for Biologics Market Size Market Share by Application in 2022
Figure 17. Global Cell Line Development for Biologics Revenue Market Share by Player in 2022
Figure 18. Global Cell Line Development for Biologics Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Cell Line Development for Biologics Market Size 2018-2023 ($ Millions)
Figure 20. APAC Cell Line Development for Biologics Market Size 2018-2023 ($ Millions)
Figure 21. Europe Cell Line Development for Biologics Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Cell Line Development for Biologics Market Size 2018-2023 ($ Millions)
Figure 23. Americas Cell Line Development for Biologics Value Market Share by Country in 2022
Figure 24. United States Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Cell Line Development for Biologics Market Size Market Share by Region in 2022
Figure 29. APAC Cell Line Development for Biologics Market Size Market Share by Type in 2022
Figure 30. APAC Cell Line Development for Biologics Market Size Market Share by Application in 2022
Figure 31. China Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Cell Line Development for Biologics Market Size Market Share by Country in 2022
Figure 38. Europe Cell Line Development for Biologics Market Size Market Share by Type (2018-2023)
Figure 39. Europe Cell Line Development for Biologics Market Size Market Share by Application (2018-2023)
Figure 40. Germany Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Cell Line Development for Biologics Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Cell Line Development for Biologics Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Cell Line Development for Biologics Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Cell Line Development for Biologics Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 54. APAC Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 55. Europe Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 57. United States Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 58. Canada Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 61. China Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 62. Japan Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 63. Korea Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 65. India Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 66. Australia Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 67. Germany Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 68. France Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 69. UK Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 70. Italy Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 71. Russia Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 72. Spain Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 75. Israel Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Cell Line Development for Biologics Market Size 2024-2029 ($ Millions)
Figure 78. Global Cell Line Development for Biologics Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Cell Line Development for Biologics Market Size Market Share Forecast by Application (2024-2029)
